¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѳ»ºÐºñÇÐȸ Á¦19ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2021-06-19

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѳ»ºÐºñÇÐȸ Á¦19ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2021-06-19
±³À°ÀÏÀÚ : 2021-06-19
±³À°Àå¼Ò : ¿Â¶óÀα³À°  
±³À°ÁÖÁ¦ : Á¦19ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­ÁÂ
ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
´ã´çÀÚ : È«Áö¼ö
¿¬¶ôó : 02-2038-3771  
À̸ÞÀÏ : endo@endocrinology.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 25ºÐ  
¼¼ºÎ¼ö°­·á : 70,000¿ø      
ºñ°í ºÀÁ÷ÀÇ/°³¿øÀÇ 5¸¸¿ø (ºñȸ¿ø 7¸¸¿ø)Àü°øÀÇ ¹× ±âŸ(±âÃÊÀÇÇÐÀÚ/°£È£»ç/¾à»ç µî) 3¸¸¿ø(ºñȸ¿ø 5¸¸¿ø)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-19 Ã¿½Ã 09:00~09:25 Coping with side effects of anti-thyroid drugs  ¹Ú¿µÁÖ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-19 Ã¿½Ã 09:25~09:50 Can we surely watch out for papillary thyroid microcarcinoma with active surveillance?  ±è¿ø¹è(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 06-19 Ã¿½Ã 09:50~10:15 Digging up the combination effects of T3 and T4  ±èº¸Çö(ºÎ»êÀÇ´ë) 
È޽Ġ06-19  10:15~10:25 Break  () 
±³À°½Ã°£ 06-19 Ã¿½Ã 10:25~10:50 Basic concept of bone modeling and remodeling  Á¤È£¿¬(°æÈñÀÇ´ë) 
±³À°½Ã°£ 06-19 Ã¿½Ã 10:50~11:15 Long-term complications in patients with hypoparathyroidism  À̽ÃÈÆ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 06-19 Ã¿½Ã 11:15~11:40 Long-term strategy in management of osteoporosis  ±èºÎ°æ(°í½ÅÀÇ´ë) 
È޽Ġ06-19  11:40~11:50 Break  () 
±³À°½Ã°£ 06-19 Ã¿½Ã 11:50~12:15 Management of hyperprolactinemia (except for prolactinomas)  Áø»ó¿í(°æÈñÀÇ´ë) 
±³À°½Ã°£ 06-19 Ã¿½Ã 12:15~12:40 Diagnosis and management of diabetes insipidus  ±èÇý¼ø(°è¸íÀÇ´ë) 
±³À°½Ã°£ 06-19 Ã¿½Ã 12:40~13:05 Novel approach to multiple endocrine neoplasia type 1  ±èÁ¤Èñ(¼­¿ïÀÇ´ë) 
È޽Ġ06-19  13:05~13:30 ½Ä»ç  () 
±³À°½Ã°£ 06-19 Ã¿½Ã 13:30~13:55 Update on the diagnosis and genetics of pheochromocytoma/paraganglioma  ±èÀçÇö(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-19 Ã¿½Ã 13:55~14:20 Diagnosis and management of polycystic ovary syndrome: Endocrinologist¡¯s viewpoint  ÀÌÇýÁø(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 06-19 Ã¿½Ã 14:20~14:55 Male hypogonadism – diagnosis and treatment  Á¶¹Îö(¼­¿ïÀÇ´ë) 
È޽Ġ06-19  14:55~15:05 Break  () 
±³À°½Ã°£ 06-19 Ã¿½Ã 15:05~15:30 Effects of GLP-1 receptor agonist on cardiovascular disease  ¿À½ÂÁØ(°æÈñÀÇ´ë) 
±³À°½Ã°£ 06-19 Ã¿½Ã 15:30~15:55 Recent research for SGLT2 inhibitor and chronic kidney disease  Çö¿µÀ²(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-19 Ã¿½Ã 15:55~16:20 Beneficial effect of initial combination therapy in patients with T2DM  ±è´ëÁß(¾ÆÁÖÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѳ»ºÐºñÇÐȸ Á¦19ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2021-06-19""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѼҾƽÉÀåÇÐȸ Á¦11ȸ ¼Ò¾Æû¼Ò³â ½ÉÃÊÀ½ÆÄ°Ë»ç ¿¬¼ö°­Á : 2021-06-19
´ÙÀ½±Û ÀÎÇÏ´ëÇб³º´¿ø (¿Â¶óÀÎ) °³¿øÀÇ ´ë»ó ¿¬¼ö±³À° : °üÀýÁúȯÀÇ ÃֽŠÁö°ß : 2021-06-19
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 4 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 7 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 3 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 6 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 3 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 6 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 1 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 1 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 1 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 1 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 3 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 1 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 3 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 1 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 5 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷